Literature DB >> 12466492

Capacity of simian immunodeficiency virus strain mac Nef for high-affinity Src homology 3 (SH3) binding revealed by ligand-tailored SH3 domains.

Marita Hiipakka1, Kalle Saksela1.   

Abstract

The simian immunodeficiency virus (SIV) Nef protein contains a consensus Src-homology 3 (SH3) binding motif. However, no SH3-domain proteins showing strong binding to SIV Nef have yet been found, and its potential capacity for high-affinity SH3 binding has therefore remained unproven. Here we have used phage-display-assisted protein engineering to develop artificial SH3 domains that bind tightly to SIV strain mac (SIVmac) Nef. Substitution of six amino acids in the RT loop region of Hck-SH3 with the sequence E/DGWWG resulted in SH3 domains that bound in vitro to SIVmac Nef much better than the natural Hck- or Fyn-SH3 domains. These novel SH3 domains also efficiently associated with SIVmac Nef when co-expressed in 293T cells and displayed a strikingly differential specificity when compared with SH3 domains similarly targeted for binding to human immunodeficiency virus type 1 (HIV-1) Nef. Thus, SIVmac Nef is competent for high-affinity SH3 binding, but its natural SH3 protein partners are likely to be different from those of HIV-1 Nef.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12466492     DOI: 10.1099/0022-1317-83-12-3147

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  3 in total

Review 1.  A new generation of protein display scaffolds for molecular recognition.

Authors:  Ralf J Hosse; Achim Rothe; Barbara E Power
Journal:  Protein Sci       Date:  2006-01       Impact factor: 6.725

2.  Endocytic sorting motif interactions involved in Nef-mediated downmodulation of CD4 and CD3.

Authors:  Santiago Manrique; Daniel Sauter; Florian A Horenkamp; Sebastian Lülf; Hangxing Yu; Dominik Hotter; Kanchan Anand; Frank Kirchhoff; Matthias Geyer
Journal:  Nat Commun       Date:  2017-09-05       Impact factor: 14.919

3.  High-affinity target binding engineered via fusion of a single-domain antibody fragment with a ligand-tailored SH3 domain.

Authors:  Annika Järviluoma; Tomas Strandin; Sebastian Lülf; Jérôme Bouchet; Anna R Mäkelä; Matthias Geyer; Serge Benichou; Kalle Saksela
Journal:  PLoS One       Date:  2012-07-05       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.